Ramiro G. Peru

CIK: 0001192045

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ELV

Elevance Health, Inc.

Director

SM Energy Co

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ELV
Elevance Health, Inc.
Jul 17, 2026
Purchase(P)
Direct
1K shares at avg. $366.05$366K
SM
SM Energy Co
Jun 22, 2026
Award(A)
Direct
6.2K shares-
SM
SM Energy Co
May 21, 2026
Sale(S)
Direct
24.6K shares at avg. $33.98$834K
ELV
Elevance Health, Inc.
May 13, 2026
Award(A)
Direct
563 shares-
SM
SM Energy Co
Jun 10, 2025
Award(A)
Direct
8K shares-
ELV
Elevance Health, Inc.
May 14, 2025
Award(A)
Direct
601 shares-
SM
SM Energy Co
Mar 4, 2025
Purchase(P)
Direct
5K shares at avg. $28.72$144K

		Type	Shares	Price		Ownership
Jul 17, 2026	ELV Elevance Health, Inc.	Purchase(P)	1,000	$366.05	$366,050	Direct
Jun 22, 2026	SM SM Energy Co	Award(A)	6,166	-	$0	Direct
May 21, 2026	SM SM Energy Co	Sale(S)	24,553	$33.98	$834,311	Direct
May 13, 2026	ELV Elevance Health, Inc.	Award(A)	563	-	$0	Direct
Jun 10, 2025	SM SM Energy Co	Award(A)	7,982	-	-	Direct
May 14, 2025	ELV Elevance Health, Inc.	Award(A)	601	-	-	Direct
Mar 4, 2025	SM SM Energy Co	Purchase(P)	5,000	$28.72	$143,600	Direct

1-7 of 7 transactions

About PERU RAMIRO G

PERU RAMIRO G (SEC CIK 0001192045) files insider reports with the SEC as Director of Elevance Health, Inc. (ELV) and Director of SM Energy Co (SM).

Signal8 holds 7 ownership filings by PERU RAMIRO G, all Form 4s, filed between Mar 5, 2025 and Jul 17, 2026. Those filings report 7 transactions, from Mar 4, 2025 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PERU RAMIRO G's filings is in INDIANAPOLIS, IN.

Recent filings by PERU RAMIRO G

Jul 17, 2026: Open-market purchase of ELV shares (Form 4, code P).
Jun 22, 2026: Grant or award of SM shares (Form 4, code A).
May 21, 2026: Open-market sale of SM shares (Form 4, code S).
May 13, 2026: Grant or award of ELV shares (Form 4, code A).
Jun 10, 2025: Grant or award of SM shares (Form 4, code A).

Other insiders filing for Elevance Health, Inc. (ELV)

Kaye Mark, EVP & CFO
Wessling Erin M, EVP & Chief Legal Officer
Craig Ryan R, EVP & Chief HR Officer
BOUDREAUX GAIL, President and CEO
Penczek Ronald W, CAO & Controller
Dixon Robert L JR, Director

How to read Form 4 transaction codes